Trademarkia Logo

Australia

AU$
CYTOSEN
Cancelled: Cancelled at the request of IB

Last updated on 13 Jul 2021

Owner Info

Kiadis Pharma Intellectual Property B.V.

Paasheuvelweg 25A

NL-1105 BP Amsterdam, THE NETHERLANDS

Serial Number

2022484 filed on 23 Jan 2019

Correspondent

Kiadis Pharma Intellectual Property B.V.

Paasheuvelweg 25A,

NL-1105 BP Amsterdam,

THE NETHERLANDS

CYTOSEN

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune diso Read More

Class [042]
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer thera Read More

Class [044]
Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; m Read More

Mark Details


Serial Number

2022484

Registered On

23 Jan 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

23 Jul 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
13th Jul 2021Status change to Voided
13th Feb 2021Full Assignment - Subsequent Owner Registered Published
11th Feb 2021Full Assignment Requested
11th Jan 2020International Registration in Australia Protected correspondence sent
10th Jan 2020IP Right Registration Published
10th Jan 2020Status change to Registered/Protected
4th Nov 2019Application Accepted correspondence sent
3rd Nov 2019IP Right Acceptance Published
3rd Nov 2019IP Right has been Examined
3rd Nov 2019Status change to Accepted